Pricing Log in Create free account

DataMeds AI, Inc (MEDS) vs 111, Inc. Sponsored ADR (YI)

DataMeds AI, Inc and 111, Inc. Sponsored ADR are both Medical Distribution companies. 111, Inc. Sponsored ADR is the larger, with a market value of $15.5M against $5.5M — 2.8× the size. 111, Inc. Sponsored ADR grew revenue faster over the last twelve months: −16.2% against −78.2%. 111, Inc. Sponsored ADR has the higher net margin (−0.75% vs −1,100.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, 111, Inc. Sponsored ADR leads on 13 and DataMeds AI, Inc on 2.

Valuation

Metric MEDS YI Medical Distribution median
P/E n/m n/m —
P/S 0.39 0.02 0.27
P/B n/m n/m —
Price to free cash flow n/m n/m —
EV/EBITDA n/m n/m 17.33
EV/Sales 2.54 0.00 0.86
Earnings yield (3,979.80%) (47.50%) (13.85%)
Free cash flow yield (470.55%) (79.83%) (6.11%)

Profitability

Metric MEDS YI Medical Distribution median
Gross margin (90.64%) 5.74% 5.74%
Operating margin (875.73%) (0.20%) 0.00%
Net margin (1,100.29%) (0.75%) (11.41%)
Free cash flow margin (182.72%) (0.71%) (0.36%)
Return on equity 949.27% 12.26% 0.00%
Return on assets (202.97%) (3.89%) (1.95%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MEDS YI Medical Distribution median
Revenue growth (TTM) (78.16%) (16.19%) 6.15%
EPS growth (last fiscal year) (853.33%) 3.14% 5.18%
Revenue growth, 5-year CAGR — 7.39% 8.18%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MEDS YI Medical Distribution median
Debt to equity (1.01) (0.34) (0.66)
Current ratio 0.14 1.08 0.99
Net debt to EBITDA (0.30) (44.78) (0.10)

Dividend

Metric MEDS YI Medical Distribution median
Dividend yield 0.00% — —
Payout ratio — — —

Size

Metric MEDS YI Medical Distribution median
Market cap 5.48m 15.47m 97.81m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack